Leadership Overview
USV Private has 7 executives leading key functions including finance, information technology, operations, and sales.
Driven by innovation, USV Private is dedicated to advancing pharmaceutical and biotechnology solutions, impacting global health through its commitment to quality and accessibility.
Driven by innovation, USV Private is dedicated to advancing pharmaceutical and biotechnology solutions, impacting global health through its commitment to quality and accessibility.
Leadership Roles at USV Private
Jogendra Sethi - Chief Financial Officer
Jogendra Sethi, the Chief Financial Officer at USV Private, directs all financial operations and strategic fiscal planning. Sethi oversees budgeting, forecasting, and financial reporting, ensuring robust fiscal health for the multinational pharmaceutical and biotechnology company. This leadership role involves managing capital allocation, optimizing investment strategies, and maintaining strong relationships with financial institutions. By driving financial efficiency, Jogendra Sethi directly supports the company's expansion initiatives and commitment to sustainable growth. The Chief Financial Officer's oversight extends to risk management and compliance, safeguarding the company's assets and ensuring adherence to regulatory standards across its global operations. Sethi's strategic financial guidance is critical for navigating market complexities and achieving long-term profitability.
Jayant Dwivedy - Executive Director & Chief Operating Officer
Jayant Dwivedy, the Executive Director & Chief Operating Officer at USV Private, drives operational excellence and strategic execution across the organization. Dwivedy oversees day-to-day business activities, ensuring efficient production, supply chain management, and quality control for the company's pharmaceutical and biotechnology products. This leadership position involves optimizing operational workflows, implementing best practices, and managing resources to meet production targets and market demands. By enhancing operational efficiency, Jayant Dwivedy directly contributes to the company's ability to deliver innovative healthcare solutions globally. The Executive Director & Chief Operating Officer's purview includes fostering cross-functional collaboration and ensuring alignment with corporate objectives. Dwivedy's strategic oversight is fundamental to maintaining USV Private's reputation for reliability and product quality.

Sunil Bhutani - President
Sunil Bhutani, the President at USV Private, leads strategic initiatives and oversees key business functions to drive company growth and market presence. Bhutani's leadership focuses on expanding the company's reach within the pharmaceutical and biotechnology sectors, ensuring alignment with overarching corporate goals. This executive role involves fostering innovation, managing critical business relationships, and guiding strategic planning to enhance market competitiveness. By directing key operational areas, Sunil Bhutani actively contributes to USV Private's mission of delivering advanced healthcare solutions. The President's responsibilities encompass driving performance across various departments and ensuring the successful implementation of strategic objectives. Bhutani's vision is instrumental in navigating industry challenges and capitalizing on emerging opportunities.
Anuj Maheshwari - President
Anuj Maheshwari, the President at USV Private, spearheads critical business development and strategic expansion efforts for the pharmaceutical and biotechnology enterprise. Maheshwari directs initiatives aimed at enhancing market penetration and fostering new growth avenues, ensuring the company's sustained competitive advantage. This senior leadership role involves cultivating strategic partnerships, identifying emerging market trends, and guiding the execution of long-term business plans. By driving strategic growth, Anuj Maheshwari directly supports USV Private's commitment to innovation and global health impact. The President's focus includes optimizing resource allocation and ensuring operational readiness for future market demands. Maheshwari's expertise is vital for navigating the complexities of the global healthcare landscape.
Esmail Samiwala - President, Biologics
Esmail Samiwala, the President, Biologics at USV Private, leads the strategic direction and operational execution of the company's biologics division. Samiwala oversees the development, manufacturing, and commercialization of innovative biologic therapies, driving advancements in biotechnology. This specialized role involves managing research and development pipelines, ensuring regulatory compliance, and expanding market access for critical biopharmaceutical products. By focusing on the biologics sector, Esmail Samiwala directly contributes to USV Private's mission of providing cutting-edge healthcare solutions. The President, Biologics' responsibilities include fostering scientific innovation and ensuring the highest standards of product quality and efficacy. Samiwala's leadership is crucial for advancing the company's capabilities in this complex and rapidly evolving field.

Singh Yogender - President (Sales & Marketing)
Singh Yogender, the President (Sales & Marketing) at USV Private, directs all sales and marketing strategies to enhance market penetration and revenue growth. Yogender oversees the development and execution of comprehensive go-to-market plans, ensuring effective product positioning and customer engagement across diverse regions. This leadership role involves managing sales teams, analyzing market dynamics, and implementing innovative marketing campaigns to strengthen brand presence in the pharmaceutical and biotechnology industries. By driving sales performance, Singh Yogender directly supports USV Private's objective of expanding access to its healthcare solutions. The President (Sales & Marketing)'s responsibilities include fostering strong customer relationships and identifying new market opportunities. Yogender's strategic vision is essential for achieving commercial success and furthering the company's global impact.
Govind Joshi - Chief Information Officer
Govind Joshi, the Chief Information Officer at USV Private, architects and executes the company's comprehensive information technology strategy. Joshi directs the development and implementation of digital infrastructure, ensuring seamless technological operations across all business units. This critical role involves overseeing data security, managing enterprise systems, and driving digital transformation initiatives to enhance operational efficiency and innovation within the pharmaceutical and biotechnology sectors. By championing advanced IT solutions, Govind Joshi ensures that USV Private maintains a competitive edge through robust technological capabilities. The Chief Information Officer's responsibilities include managing IT budgets, leading technology teams, and fostering a culture of technological advancement. Joshi's leadership ensures the integrity and accessibility of information systems, supporting the company's mission to deliver high-quality healthcare solutions.
Explore Leadership Teams in Manufacturing
Pfizer is a biopharmaceutical company that researches, develops, manufactures, and markets medicines and vaccines across multiple therapeutic areas. The company focuses on areas such as oncology, internal medicine, inflammation and immunology, and vaccines to help prevent, treat, and manage disease worldwide.
Company Leadership PC
AK
SK
SR
Founded in 1891, Adcock Ingram is a pharmaceutical manufacturer headquartered in Gauteng, South Africa. Adcock Ingram manufactures, markets and distributes a range of healthcare products.
Company Leadership AH
WR
FC
GH
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed, and grain processors and processors; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topical and diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segments products are also used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was founded in 1981 and is headquartered in Lansing,...
Company Leadership DK
KB
CD
Organon creates, manufactures and markets innovative prescription medicines that improve the health and quality of human life. Through a combination of innovation and business partnerships, Organon seeks to leverage each of its core therapeutic fields.
Company Leadership
AL
JS
MA